3DMedTALKS | The additive response to COVID-19

In this podcast, in collaboration with Women in 3D Printing, we invited experts to discuss how the additive manufacturing community has responded to coronavirus.

Like Comment

In the face of the COVID-19 pandemic, innovators are finding novel ways to apply 3D-printed solutions to assist the international response to coronavirus. 

From meeting PPE demands, to designing novel approaches to unique challenges, the additive community has not been short of opportunity for collaboration and corroboration with multidisciplinary teams exploring options for aiding crises from local to international capacities.  

In this podcast, in collaboration with Women in 3D Printing, we invited a panel of experts to take a look at how the additive community has responded to coronavirus, where the limitations lie in integrating 3D-printed devices into a health system under pressure as well as what can be done by the wider 3D printing community to help overcome critical challenges posed by COVID-19.  

If you would be interested in working with us on a podcast or similar project, get in touch with us today.

Questions

  • How have SHIELD Collaborative (London, UK) and Materialise (Leuven, Belgium) responded to COVID-19? [04:26]
  • Once you had the ideas and designs and had proved the concept that these devices worked, what were the next crucial steps and key challenges that had to be overcome? [10:22]
  • Other than following appropriate regulatory guidance, what else is important to consider when testing and validating devices and pieces of critical equipment? [12:32]
  • Once the important validation step has been achieved, what is the next step in scaling up a 3D-printed part? [16:22]
  • Considering the clinical perspective, what is important to consider when introducing a medical device or innovative idea into a health system under pressure? [18:20]
  • In future waves of COVID-19 or in the future emergence of a different virus or infection, could the additive response be a system or strategy that health systems could rely on when faced with a situation likely to cause strain on public health resources? [27:06]
  • What have people learned about 3D printing and additive manufacturing community in the wake of the additive response to COVID-19? [33:40]
  • What has the additive manufacturing community learned in response to the COVID-19 crisis? [36:36]
  • What has the medical community learned about additive manufacturing following the additive response to COVID-19? [38:02]
  • What skills we be required by the next generation of clinicians, makers, innovators... to meet the next generation of challenges with the next generation of technologies? [40:58]
  • Where can we go to find out more about 3D printing and about joining the additive response to COVID-19? [44:52]

You may also be interested in: 


Meet the experts

Maxine Chan

Director of Med Supply Drive UK, NHS Obstetrician and Gynaecologist, PhD Researcher in Bioengineering and Regenerative Medicine, Imperial College London (UK)

Maxine Chan is an NHS Doctor and Researcher in London with a research interest in innovative bioengineering solutions to treating female reproductive health issues. Chan is also the Director of Med Supply Drive UK (London, UK), an organization of volunteer medics and non-medics who are protecting frontline healthcare workers during the COVID-19 crisis by providing solutions to PPE shortages.

Brigitte De Vet-Veithen

VP and General Manager, Materialise Medical

Brigitte de Vet-Veithen has been the Vice President of Materialise Medical since June 2016, as a representative of De Vet Management bvba. De Vet-Veithen has almost 20 years of experience in the healthcare and life sciences sector. She has worked in various management roles for Johnson & Johnson (NJ, USA), ultimately serving as Vice President for the EMEA region of Cordis Neurovascular and General Manager of Cordis (CA, USA) in Germany. Before joining Materialise (Leuven, Belgium), she held various leadership roles as a representative of De Vet Management bvba including the role of Chief Executive Officer of Acertys group (Aartselaar, Belgium), a provider of medical devices, software, services and supplies to hospitals and medical professionals. De Vet-Veithen holds a Master of Business Administration with a Major in Engineering from HEC Liege (Belgium) and an MBA from INSEAD (Fontainebleau, France).

Kate Hammer

Co-Founding Committee Member, SHIELD Collaborative

Kate Hammer is an innovation specialist ranging across architecture/engineering, biotechnology, chemical, FMCG, healthcare, information, public health and technology sectors, often working with scientists of all descriptions to realize demanding projects, often at speed.

Kadine James

Co-Founder, SHIELD Collaborative

Learner, maker, innovator and 3D technology enthusiast, Kadine James is the Creative Tech Lead at Hobs 3D (London, UK) and is a prominent UK tech evangelist. Combining 7+ years’ experience in 3D printing, virtual reality, augmented reality and mixed reality, James is driven by big ideas, a global mind-set and empowering the use 3D printing in art and architecture. She sets out to create a platform for 3D printing VR/AR/MR learning opportunities for young people to get involved with 3DTech in central London, at Hobs 3D’s hub and incubator for thought leadership.

James is UK Lead of Women in 3D Printing, a global platform which inspires, encourages and supports women working with rapid prototyping technologies – and is one of the first Industry Champions for the Creative Industries Policy & Evidence Centre network (led by Nesta). James is listed as one of the top 100 most influential women in UK Tech. 

Go to the profile of 3DMedNet

3DMedNet

eCommunity, Future Science Group

3DMedNet is a networking site where users can share their knowledge and insights. This profile will share some content and updates from the 3DMedNet team, including webinars, news and journal articles.

No comments yet.